Leading small business
innovation and commercialization
in the fight against cancer
The SBIR & STTR Programs are one of the largest sources of early stage technology financing in the United States. We welcome entrepreneurs and small business leaders to this website to explore grant and contract funding opportunities.
Learn how NCI SBIR & STTR Programs have helped small businesses with funding awards that help advance cancer research.
Their MxStructure™ software uses auto-segmentation to better focus radiation treatment and minimize exposure to surrounding healthy tissue. They were acquired by Accuray in 2012.
Developed LuViva, a non-invasive medical device designed to instantly detect cervical disease in a point-of-care setting with a $2.5 million Bridge Award.
Awarded more than $4 million to develop a technology platform of safe and effective carriers for therapeutic vaccines based on hemocyanin from the keyhole limpet (KLH) protein.
The NCI SBIR Program announced 14 new contract funding opportunities. Electronic submissions are now accepted. The receipt date is October 16, 2015.
NOTE SPECIAL DUE DATE SEPTEMBER 8, 2015 (September 5 is a weekend and September 7 is a Federal Holiday) Receipt dates: September 8, 2015; January 5, 2016; April 5, 2016
Download slides from a webinar about the I-Corps™ at NIH pilot program, which seeks to accelerate development and commercialization of new SBIR/STTR-funded products and services.
NIH is changing its Standard Due Dates for SBIR & STTR grant applications.
This site is undergoing remediation for compliance with Section 508. The remediation will be complete by July 31, 2015.
In the interim, should you require any accessibility assistance with any content, please contact NCI SBIR & STTR